AXA Private Equity Carves Out Rhodia's Aspirin Unit
AXA Private Equity, the international buyout arm of French insurer AXA Group, has acquired Rhodia SA's aspirin and salicylic acid unit through a pharmaceutical subsidiary to build its chemical holdings, the...To view the full article, register now.
Already a subscriber? Click here to view full article